Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

MEDICAL EXERCISE INC Common Stock · MDXR

MDXROTCCommon stockCurrentCIK 2001249Updated Nov 14, 2026

Company: MEDICAL EXERCISE INC. →

Name history
MEDX BACK PAIN CLINICS INC. · through Nov 16, 2023

MDXR price & chart

Provider market data

Loading TradingView…

OTC:MDXR on TradingView ↗

TradingView · Data may be delayed

In the news

No coverage from other publishers is available.

Recent filings

  1. NT 10-Q filing

    NT 10-Q · 2026-11-13 · 0001213900-26-119622

  2. 10-Q filing

    10-Q · 2026-08-19 · 0001213900-26-091600

  3. NT 10-Q filing

    NT 10-Q · 2026-08-14 · 0001213900-26-090132

  4. 10-K filing

    10-K · 2026-06-29 · 0001213900-26-073032

  5. D filing

    Items 04

    D · 2026-05-19 · 0001213900-26-058787

Show 5 more recent filings
  1. D/A filing

    Items 04

    D/A · 2026-05-18 · 0001213900-26-058125

  2. D/A filing

    Items 04

    D/A · 2026-05-15 · 0001213900-26-057793

  3. Entry into a Material Definitive Agreement · Regulation FD Disclosure

    Items 1.01, 7.01, 9.01

    8-K/A · 2026-05-08 · 0001213900-26-054034

  4. Entry into a Material Definitive Agreement · Regulation FD Disclosure

    Items 1.01, 7.01, 9.01

    8-K · 2026-05-08 · 0001213900-26-053475

  5. 10-Q filing

    10-Q · 2026-02-13 · 0001213900-26-016247

Financials

FY 2026 · USD
Revenue— · FY 2026
Net income-226,708USD · FY 2026
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

Operating income-222,363USD · FY 2026
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

Diluted EPS-0.02USD per share · FY 2026
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2026FY 2025
ASSETS
AssetsUSD61,330
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

65,261
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Property, Plant and Equipment, NetUSD15,924
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

59,903
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD43,449
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

450
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Assets, CurrentUSD43,449
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

450
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

LIABILITIES AND EQUITY
Stockholders’ equity:
Common Stock, Value, IssuedUSD522,700
Source

10-Q · 2026-08-19 · 0001213900-26-091600

As of 2026-06-30

412,200
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Retained Earnings (Accumulated Deficit)USD-705,707
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

-478,999
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Stockholders' Equity Attributable to ParentUSD-183,507
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

-67,299
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Liabilities and EquityUSD61,330
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

65,261
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Current liabilities:
Liabilities, CurrentUSD244,837
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

132,560
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2026FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD8,736
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

11,492
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Share-based Payment Arrangement, Noncash ExpenseUSD2,000
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

100,000
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Deferred Income Tax Expense (Benefit)USD66,514
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-83,668
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Net Cash Provided by (Used in) Operating ActivitiesUSD-194,751
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-191,027
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD33,849
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-5,685
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Payments to Acquire Property, Plant, and EquipmentUSD—3,869
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD203,901
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

186,505
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD43,449
Source

10-K · 2026-06-29 · 0001213900-26-073032

As of 2026-03-31

450
Source

10-K · 2025-07-14 · 0001213900-25-063676

As of 2025-03-31

Additional Financial Items
AmortizationUSD—2,122
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Amortization of Intangible AssetsUSD2,758
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

—
DepreciationUSD5,978
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

9,370
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Gain (Loss) on Disposition of Intangible AssetsUSD-2,550
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

—
Gain (Loss) on Disposition of Property Plant EquipmentUSD-1,795
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

389
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD—-331,374
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Net Income (Loss) Attributable to ParentUSD-226,708
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-330,985
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Nonoperating Income (Expense)USD-4,345
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

389
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Operating ExpensesUSD222,363
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

332,223
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Other Depreciation and AmortizationUSD8,735
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

—
Proceeds from Issuance of Common StockUSD108,500
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

15,500
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2026FY 2025
Total RevenueUSD—1,294
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Cost of Goods and Services Sold——
Gross Profit (Calculated) · Derived——
Selling, General and Administrative ExpenseUSD—176,271
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Operating Income (Loss)USD-222,363
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

849
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-226,708
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-330,985
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Net Income (Loss) Attributable to ParentUSD-226,708
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-330,985
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Earnings Per Share, BasicUSD per share-0.02
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-0.03
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Earnings Per Share, DilutedUSD per share-0.02
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

-0.03
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Weighted Average Number of Shares Outstanding, Basicshares12,599,986
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

12,187,151
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Weighted Average Number of Shares Outstanding, Dilutedshares12,599,986
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

12,187,151
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Additional Financial Items
Amortization of Intangible AssetsUSD2,758
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

—
Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD—-331,374
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Nonoperating Income (Expense)USD-4,345
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

389
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Operating ExpensesUSD222,363
Source

10-K · 2026-06-29 · 0001213900-26-073032

2025-04-01 to 2026-03-31

332,223
Source

10-K · 2025-07-14 · 0001213900-25-063676

2024-04-01 to 2025-03-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ea028988301ex99-1.htm · 8-K/A · 2026-05-08

Exhibit 99.1 FOR IMMEDIATE RELEASE Medical Exercise Inc. Signs First Franchise in Regina, Canada ST PETERSBURG, FL - May 6, 2026 - Medical Exercise Inc. is proud to announce a transformative leap in the global health span market with the signing of its first OnCore Longevity Center franchise agreement. Degco Fitness Ventures Ltd., a company owned by our President, intends to open its flagship Canadian facility at 4057 Albert Street, Regina, SK, with operations projected to commence in Septemb…

8-K/A · 2026-05-08 · 0001213900-26-054034

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.